the Consolidated Financial Statements ended 31 December 2018, which have been audited by the Company’s authorized auditor. The Company would like to clarify the operating results of the Company and its
amount not exceeding 200 MB; totaling to not exceeding 250 MB. In order to expand investment in business concerning healthcare, esthetic, and cosmetic distribution related to core business of the Company
trademark “Wuttisak Clinic” at the amount not exceeding 200 MB; totaling to not exceeding 250 MB. In order to expand investment in business concerning healthcare, esthetic, and cosmetic distribution related
Group Public Company Limited (the “Company” or “CBG”), are pleased to submit management discussion and analysis regarding consolidated financial performance and position of the Company and subsidiaries
Limited and its subsidiaries For the Three-month period and Six-month period ended 30th June 2017 1. Overall performance Consolidated financial results of Patum Rice Mill and Granary Public Company Limited
Limited and its subsidiaries For the Three-month period and Nine-month period ended 30th September 2017 1. Overall performance Consolidated financial results of Patum Rice Mill and Granary Public Company
which had been audited by the independent auditor as follows: Consolidated financial statements The Group Company reported profit attributable to owners of the Company for the year 2018 in the amount of
quarter ended 31 March 2019 which had been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners of the Company for Q1/2019 in
the “Group”) for the second quarter ended 30 June 2019 which had been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners
the first quarter ended 31 March 2018 which has been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners of the Company for